164 related articles for article (PubMed ID: 37935848)
1. Mammographic features and risk of breast cancer death among women with invasive screen-detected cancer in BreastScreen Norway 1996-2020.
Moshina N; Backmann HA; Skaane P; Hofvind S
Eur Radiol; 2024 May; 34(5):3364-3374. PubMed ID: 37935848
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer cases.
Koch HW; Larsen M; Bartsch H; Kurz KD; Hofvind S
Eur Radiol; 2023 May; 33(5):3735-3743. PubMed ID: 36917260
[TBL] [Abstract][Full Text] [Related]
3. Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review.
Tsuruda KM; Hovda T; Bhargava S; Veierød MB; Hofvind S
Eur Radiol; 2021 May; 31(5):2677-2686. PubMed ID: 33180162
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
5. Mode of detection: an independent prognostic factor for women with breast cancer.
Hofvind S; Holen Å; Román M; Sebuødegård S; Puig-Vives M; Akslen L
J Med Screen; 2016 Jun; 23(2):89-97. PubMed ID: 26582492
[TBL] [Abstract][Full Text] [Related]
6. Radiological review of prior screening mammograms of screen-detected breast cancer.
Hovda T; Tsuruda K; Hoff SR; Sahlberg KK; Hofvind S
Eur Radiol; 2021 Apr; 31(4):2568-2579. PubMed ID: 33001307
[TBL] [Abstract][Full Text] [Related]
7. AI Risk Score on Screening Mammograms Preceding Breast Cancer Diagnosis.
Larsen M; Olstad CF; Koch HW; Martiniussen MA; Hoff SR; Lund-Hanssen H; Solli HS; Mikalsen KØ; Auensen S; Nygård J; Lång K; Chen Y; Hofvind S
Radiology; 2023 Oct; 309(1):e230989. PubMed ID: 37847135
[TBL] [Abstract][Full Text] [Related]
8. Mammographic casting-type calcification associated with small screen-detected invasive breast cancers: is this a reliable prognostic indicator?
Peacock C; Given-Wilson RM; Duffy SW
Clin Radiol; 2004 Feb; 59(2):165-70; discussion 163-4. PubMed ID: 14746787
[TBL] [Abstract][Full Text] [Related]
9. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
10. Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers?
James JJ; Evans AJ; Pinder SE; Macmillan RD; Wilson AR; Ellis IO
Clin Radiol; 2003 Jan; 58(1):54-62. PubMed ID: 12565206
[TBL] [Abstract][Full Text] [Related]
11. Patterns of aggressiveness: risk of progression to invasive breast cancer by mammographic features of calcifications in screen-detected ductal carcinoma in situ.
Lilleborge M; Falk RS; Hovda T; Holmen MM; Ursin G; Hofvind S
Acta Radiol; 2022 May; 63(5):586-595. PubMed ID: 33887963
[TBL] [Abstract][Full Text] [Related]
12. Do mammographic tumor features in breast cancer relate to breast density and invasiveness, tumor size, and axillary lymph node involvement?
Sartor H; Borgquist S; Hartman L; Olsson Å; Jawdat F; Zackrisson S
Acta Radiol; 2015 May; 56(5):536-44. PubMed ID: 24814360
[TBL] [Abstract][Full Text] [Related]
13. Performance of an Artificial Intelligence System for Breast Cancer Detection on Screening Mammograms from BreastScreen Norway.
Larsen M; Olstad CF; Lee CI; Hovda T; Hoff SR; Martiniussen MA; Mikalsen KØ; Lund-Hanssen H; Solli HS; Silberhorn M; Sulheim ÅØ; Auensen S; Nygård JF; Hofvind S
Radiol Artif Intell; 2024 May; 6(3):e230375. PubMed ID: 38597784
[TBL] [Abstract][Full Text] [Related]
14. Tumour characteristics of bilateral screen-detected cancers and bilateral interval cancers in women participating at biennial screening mammography.
van Bommel R; Lameijer JRC; Voogd AC; Nederend J; Louwman MWJ; Setz-Pels W; Strobbe LJ; Tjan-Heijnen VCG; Duijm LE
Eur J Radiol; 2018 Nov; 108():215-221. PubMed ID: 30396659
[TBL] [Abstract][Full Text] [Related]
15. Radiological findings of screen-detected cancers in a multi-centre randomized, controlled trial of mammographic screening in women from age 40 to 48 years.
Evans AJ; Kutt E; Record C; Waller M; Moss S
Clin Radiol; 2006 Sep; 61(9):784-8. PubMed ID: 16905387
[TBL] [Abstract][Full Text] [Related]
16. Screening at stationary versus mobile units in BreastScreen Norway.
Holen Å; Sebuødegård S; Waade GG; Aase H; Hopland NM; Pedersen K; Larsen M; Tsuruda KM; Hofvind S
J Med Screen; 2020 Mar; 27(1):31-39. PubMed ID: 31554445
[TBL] [Abstract][Full Text] [Related]
17. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
Hofvind S; Møller B; Thoresen S; Ursin G
Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
[TBL] [Abstract][Full Text] [Related]
18. Mammographic density and risk of breast cancer by tumor characteristics: a case-control study.
Krishnan K; Baglietto L; Stone J; McLean C; Southey MC; English DR; Giles GG; Hopper JL
BMC Cancer; 2017 Dec; 17(1):859. PubMed ID: 29246131
[TBL] [Abstract][Full Text] [Related]
19. Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway.
Tsuruda KM; Larsen M; Román M; Hofvind S
Cancer; 2022 Apr; 128(7):1373-1380. PubMed ID: 34931707
[TBL] [Abstract][Full Text] [Related]
20. Interval and Consecutive Round Breast Cancer after Digital Breast Tomosynthesis and Synthetic 2D Mammography versus Standard 2D Digital Mammography in BreastScreen Norway.
Hovda T; Holen ÅS; Lång K; Albertsen JL; Bjørndal H; Brandal SHB; Sahlberg KK; Skaane P; Suhrke P; Hofvind S
Radiology; 2020 Feb; 294(2):256-264. PubMed ID: 31821118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
